Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q2 FY24 results · Jul–Sep 2023
Max Healthcare Institute reported revenue from operations of ₹1,363.16 crore (up 19.9% from Q2 FY23) and net profit of ₹276.68 crore (down 39.5% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,363.16 | 1,137.12 | +19.9% | 1,284.99 | +6.1% |
| Other income | 45.48 | 25.82 | +76.1% | 41.32 | +10.1% |
| Total income | 1,408.64 | 1,162.94 | +21.1% | 1,326.31 | +6.2% |
| Profit before tax | 366.42 | 265.22 | +38.2% | 303.49 | +20.7% |
| Net profit for the period | 276.68 | 457.35 | −39.5% | 240.08 | +15.2% |
| EPS, basic (₹) | 2.85 | 4.72 | −39.6% | 2.47 | +15.4% |
| Net margin (%) | 20.3 | 40.2 | 18.7 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 596.87 | 474.14 | +25.9% | 543.63 | +9.8% |
| Other income | 48.04 | 32.16 | +49.4% | 42.73 | +12.4% |
| Total income | 644.91 | 506.30 | +27.4% | 586.36 | +10.0% |
| Profit before tax | 210.03 | 144.01 | +45.8% | 160.98 | +30.5% |
| Net profit for the period | 161.31 | 358.64 | −55.0% | 126.06 | +28.0% |
| EPS, basic (₹) | 1.66 | 3.70 | −55.1% | 1.30 | +27.7% |
| Net margin (%) | 27.0 | 75.6 | 23.2 |
Consolidated
- Filed with BSE
- 07 Nov 2023, 13:24 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2023, 13:24 IST
- Board meeting
- 06 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE